SOPHiA GENETICS SOPH
NASDAQ SOPH
$8.09 -0.21 (-2.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

SOPHiA GENETICS (SOPH) Long-Term Investments (2025 - 2026)

SOPHiA GENETICS's (SOPH) quarterly Long-Term Investments came in at $2.0 million in Q1 2026, down 0.96% quarter-over-quarter from $2.0 million in Q4 2025.

Analysis

SOPHiA GENETICS (SOPH) Long-Term Investments (2025 - 2026) Analysis & Trends

SOPHiA GENETICS has disclosed Long-Term Investments across 2 years of filings, most recently posting $2.0 million for Q1 2026.

  • In Q1 2026, Long-Term Investments changed N/A year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
  • Long-Term Investments came in at $2.0 million for Q1 2026 at SOPHiA GENETICS, down from $2.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.0 million in Q4 2025 to a low of $493000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Veeva Systems 44.53 Bn 37.29 Bn 695.95 Mn -
2 Waystar Holding 4.81 Bn 4.62 Bn 221.99 Mn -
3 Doximity 4.74 Bn 4.05 Bn 132.93 Mn -
4 CCC Intelligent Solutions Holdings 4.41 Bn 4.30 Bn 210.64 Mn 10.23 Mn
5 EverCommerce 1.40 Bn 1.27 Bn 119.50 Mn -
6 Schrodinger 1.32 Bn 904.47 Mn 32.43 Mn 39.05 Mn
7 Certara 1.21 Bn 1.03 Bn 58.15 Mn -
8 GoodRx Holdings 1.18 Bn 887.53 Mn 179.41 Mn -
9 Healthstream 853.81 Mn 787.08 Mn 54.72 Mn -
10 SOPHiA GENETICS 554.05 Mn 446.39 Mn 15.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.96 Mn
Dec 31, 2025 1.98 Mn
Sep 30, 2025 493,000.00